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Abstract
Background: Delay in the diagnosis of tuberculosis (TB) results in excess morbidity and mortality,
particularly among HIV-infected individuals. This study was conducted at a secondary level hospital
serving communities with a high HIV prevalence in Cape Town, South Africa. The aim was to
describe patient and provider delay in the diagnosis of TB in patients with suspected TB requiring
admission, and to determine the risk factors for this delay and the consequences.
Methods: A cross-sectional study was conducted. Patients admitted who were TB suspects were
interviewed using a structured questionnaire to assess history of their symptoms and health seeking
behaviour. Data regarding TB diagnosis and outcome were obtained from the medical records.
Bivariate associations were described using student's T-tests (for means), chi-square tests (for
proportions), and Wilcoxon rank-sum tests (for medians). Linear regression models were used for
multivariate analysis.
Results: One hundred twenty-five (125) patients were interviewed. In 104 TB was diagnosed and
these were included in the analysis. Seventy of 83 (84%) tested were HIV-infected. Provider delay
(median = 30 days, interquartile range (IQR) = 10.3–60) was double that of patient delay (median
= 14 days, IQR = 7–30). Patients had a median of 3 contacts with formal health care services before
referral. Factors independently associated with longer patient delay were male gender, cough and
first health care visit being to public sector clinic (compared with private general practitioner).
Patient delay ≥ 14 days was associated with increased need for transfer to a TB hospital. Provider
delay ≥ 30 days was associated with increased mortality.
Conclusion: Delay in TB diagnosis was more attributable to provider than patient delay, and
provider delay was associated with increased mortality. Interventions to expedite TB diagnosis in
primary care need to be developed and evaluated in this setting.
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Background
Delay in diagnosis is an important contributor to the
excess morbidity and mortality of tuberculosis (TB) in
HIV-infected people [1,2]. Delay in the diagnosis of TB in
HIV-infected individuals has a greater impact on mortality
and morbidity when compared with HIV-uninfected indi-
viduals because TB presents more commonly with dissem-
ination [3] and disease progression is more rapid [4]. In
addition, HIV disease progression is accelerated and viral
load increased by TB [5-7] and a delayed TB diagnosis
exacerbates this [8].
There are increased costs associated with a delayed diag-
nosis, both to the patient in terms of lost employment and
visits to the health care system and to the health care sys-
tem in terms of additional clinic visits and the need for
hospitalisation. Also, a delay in diagnosis means that the
untreated individual remains an infectious risk in the
community for longer, contributing to increased TB trans-
mission [9].
This study quantified diagnostic delay, associated factors,
and consequences in patients requiring admission with
suspected TB to a community-based secondary level hos-
pital serving communities with a high HIV prevalence in
Cape Town, South Africa (GF Jooste Hospital). The hospi-
tal serves a population of 1.3 million people. During the
study period the main community served by the hospital
had an antenatal HIV prevalence of 27% and a TB inci-
dence of 1416/100 000 per annum.
Methods
This was a cross-sectional study. Data were collected using
an interviewer-administered semi-structured question-
naire. All TB suspects who were admitted to the medical
wards at GF Jooste Hospital between February and Sep-
tember 2003 were approached while in the ward for par-
ticipation. Most of the TB diagnostic work-up in this
setting takes place at government-funded public sector
primary care facilities. Ill patients requiring admission are
referred to the hospital by these facilities or by a private
general practitioner (GP). The study was conducted prior
to antiretroviral therapy (ART) being available in the pub-
lic sector in South Africa and no patients in the study were
on ART. There was also no isoniazid (INH) preventive
therapy programme in the public or private sector.
Patients 18 years or older were recruited. Exclusion criteria
were treatment for TB within the preceding 6 months,
confusion, and being a TB suspect solely on the basis of
suspected TB meningitis. Patients were not recruited if
admitted over weekends or during the two periods of
leave taken by the interviewer. Participants gave written
consent. The interviews were conducted by a trained inter-
viewer in the patient's home language. Data on patients'
socio-demographic and economic profile, symptoms,
timing of seeking medical attention and type of health
provider visited, and knowledge, attitudes and beliefs
(KAB) were collected. The KAB questions were open-
ended and the answers were coded into categories for
analysis.
Patients with an unknown HIV serostatus were offered
HIV testing with pre- and post- test counselling upon
completion of the interview. The test for HIV, using the
Abbott Determine HIV-1/2, was conducted in a labora-
tory. Those with a previous diagnosis of HIV at another
institution were not retested as long as this diagnosis was
documented in the referral letter. Data regarding TB diag-
nosis and outcome were obtained from the medical
records.
The main inclusion criterion was a TB suspect, defined as
referral from a primary care facility for diagnostic work-up
for TB or in whom the admitting doctor suspected TB.
Patients were followed up to assess whether the final diag-
nosis made by the admitting doctors was TB, but no
attempt was made to influence their diagnostic process.
The diagnosis of TB was divided into three categories: pos-
sible, probable and definite. The diagnosis was regarded
as possible if both the clinical picture and radiological
findings were assessed by a senior clinician to be compat-
ible with TB, but microscopy and culture were negative or
not done. Probable TB was diagnosed if acid fast bacilli
(AFBs) were found on microscopy of any sample, or if
granulomas were detected on histological or cytological
examination. Definite TB was diagnosed if a culture grew
Mycobacterium tuberculosis (MTB). Those with a diagnosis
of TB were included in analysis.
Patient delay was defined as the time from the first symp-
tom to seeking medical attention in the formal health
services. Total delay was defined as time from first symp-
tom to admission to GF Jooste. Provider delay was calcu-
lated by subtracting patient delay from total delay. These
delays reflected outpatient delay. Inpatient delay was cal-
culated separately, being defined as the duration from the
day of admission to the hospital's casualty department to
the day TB treatment was initiated. Constitutional symp-
toms were defined as one or more of tiredness, generalised
weakness, anorexia or reported weight loss.
The first author gathered the medical data from patient
records. Data were entered on an Epi-info 6 database and
statistical analysis was done using STATA 8.0. Frequency
distributions and univariate descriptive statistics were
used for preliminary analyses. Bivariate associations were
described using student's T-tests (for means), chi-square
tests (for proportions), and Wilcoxon rank-sum tests (for
medians). Variables that demonstrated significant bivari-BMC Infectious Diseases 2008, 8:72 http://www.biomedcentral.com/1471-2334/8/72
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ate association (defined as p ≤ 0.05) with patient delay
were entered into linear regression models, developed to
assess independent effects. Variables were retained in the
final model if they demonstrated significant independent
association (defined as p ≤ 0.05) with patient delay, or if
their removal altered the association between other cov-
ariates and patient delay.
Ethical approval for the study was obtained from the Uni-
versity of Cape Town Faculty of Health Sciences Research
Ethics Committee (Reference number: 210/2001).
Results
One hundred and sixty two TB suspects were approached
for participation. The reasons for exclusion from the study
are shown in Figure 1; 125 patients were interviewed.
Among these 125 patients, in 97 a specimen was sent for
TB microscopy. TB culture was performed in 62 cases. TB
was diagnosed in 83% (n = 104). Among these, TB diag-
nosis was definite in 39% (n = 41), probable in 33% (n =
34) and possible in 28% (n = 29). TB was pulmonary in
38% (n = 39), pulmonary with extrapulmonary in 56% (n
= 58), and extrapulmonary alone in 7% (n = 7). Of these
104 patients, 93 were started on TB treatment, 3 died
before TB treatment could be started, and in 3 TB treat-
ment was not started for unclear reasons or because the
culture result only came back after discharge. Five
patients, in whom the diagnosis of TB was not made dur-
ing the admission because the diagnosis was not certain,
were referred to their local TB clinic for follow up of TB
culture results which were subsequently positive. Among
those started on TB treatment during the admission the
median inpatient delay to starting TB treatment was 1 day.
TB treatment was started on the day of admission in 35%
(n = 33).
Of the 41 patients who had a culture that grew MTB, 10
had drug susceptibility testing for INH and rifampicin per-
formed using direct proportions method. In one patient
INH monoresistance was demonstrated and in another
multi-drug resistant MTB. The other 8 demonstrated MTB
susceptible to both drugs.
Diagnoses other than TB were made in 17% (n = 21): bac-
terial pneumonia (n = 9), Pneumocystis jirovecii pneumo-
nia (n = 3), chronic lung disease with secondary infection
(4, one of whom also had disseminated Kaposi's sar-
coma), bacterial empyema (n = 3), lung abscess (n = 1)
and bacterial pneumonia and meningitis (n = 1).
Further analysis was restricted to those 104 patients with
a diagnosis of TB.
Patient characteristics
Characteristics of those patients diagnosed with TB are
shown in Table 1. Their median age was 30 years (inter-
quartile range, IQR = 25–38.5). Thirty percent (n = 31)
had previously had TB, one of whom had defaulted treat-
ment. HIV serostatus was 42% (n = 44) known seroposi-
tive before admission, 25% (n = 26) diagnosed
seropositive during the study, 13% (n = 13) tested HIV
seronegative, and 20% (n = 21) declined HIV testing. HIV
infection prevalence was thus 84 % in those in whom sta-
tus was known (70/83).
Symptoms
Their commonest initial symptoms were constitutional (n
= 44, 42%), cough (n = 38, 37%) and chest pain (n = 5,
5%). The commonest symptoms to be reported during the
course of the illness were: constitutional (n = 95, 91%),
cough (n = 81, 78%), febrile symptoms (n = 55, 53%),
dyspnoea (n = 52, 50%), chest pain (n = 38, 37%) and
gastro-intestinal (n = 31, 30%).
Reasons for exclusion from study among 162 patients  approached Figure 1
Reasons for exclusion from study among 162 patients 
approached. 162 admitted patients with suspected tubercu-
losis (TB) were approached to participate in the study, of 
which 104 are included in the analysis. The reasons for the 
exclusion of the other patients are shown.
162 patients with suspected TB approached 
5 unwilling to participate 
32 excluded  17 confused 
1 deaf 
7 on TB treatment within last 
6 months 
125 patients interviewed 
3 TB meningitis suspects 
4 medical records missing 
104 patients diagnosed with TB and included in analysis
21 diagnosed with condition other than TBBMC Infectious Diseases 2008, 8:72 http://www.biomedcentral.com/1471-2334/8/72
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Twenty-five percent (n = 26) were working before they fell
ill. Of these, 92% (n = 24) stopped working during their
illness. Eighty-four percent (n = 87) were too ill to leave
their home for a median of 30 days (interquartile range
(IQR) = 21–60) before admission; and 75% (n = 78) had
been bed-bound for a median of 10.5 days (IQR = 7–14).
Health care utilisation
Fifteen percent (n = 16) reported using a home remedy. In
a third of these patients, this was a cough mixture. Four-
teen percent (n = 15) visited a traditional healer, four of
them on more than one occasion. Patients had a median
of 3 contacts (IQR = 2–4) with the formal health services
at the time of referral to GF Jooste. Eighty-eight percent (n
= 91) visited a public sector clinic and 57% (n = 59) vis-
ited a GP on one or more occasion during the course of
their illness. The health providers visited and patterns of
consultation are shown in Table 2.
Thirty-eight percent (n = 39) reported having had a spu-
tum specimen taken during the course of their illness
before admission and less than one-half of these (n = 18)
were told the result of the test (negative in 83%, n = 15).
Nine patients were unable to attend for the result because
they were too weak. Forty-eight percent (n = 50) reported
having had one or more chest radiographs performed
prior to admission. GPs requested no sputum samples
and 3 chest radiographs in the 59 patients who consulted
them.
Delay
The median total delay from onset of symptoms to admis-
sion was 60 days (IQR = 30–90), median patient delay
was 14 days (IQR = 7–30) and median provider delay was
30 days (IQR = 10.3–60).
Factors associated with delay (Table 3)
In bivariate analysis, longer patient delay was associated
with male gender, the health care service the patient first
visited and cough being reported as a symptom. In multi-
variate analysis the following factors were independently
significantly associated with longer patient delay: male
gender (p = 0.02), having cough as a symptom (p = 0.02)
Table 1: Characteristics of the 104 patients with a diagnosis of 
tuberculosis
n%
Gender
Male 39 37.5
Female 65 62.5
First language
Xhosa 90 86.5
Afrikaans 6 5.8
Other 8 7.7
Marital status
Single 67 64.4
Married 15 14.4
Living together 18 17.3
Widowed 4 3.8
Dependents*
Nil 19 18.6
12 6 2 5 . 5
22 3 2 2 . 5
31 5 1 4 . 7
≥41 9 1 8 . 6
Employment status
Unemployed 65 62.5
Employed 23 22.1
Grant 10 9.6
Casual work 2 1.9
Student 2 1.9
Pensioner 2 1.9
Formal education**
None 5 4.9
Primary 22 21.4
Secondary 74 71.8
Studied after school 2 1.9
*Data for 2 patients were missing
**Data for 1 patient were missing
Table 2: Health provider visits prior to admission for the 104 
patients with a diagnosis of tuberculosis
n%
Category of health provider visited
Public sector clinic 91 87.5
GP 59 56.7
Traditional healer 15 14.4
Secondary or tertiary hospital 11 10.6
Visited category of provider 3 or more times
Public sector clinic 30 28.8
GP 15 14.4
Traditional healer 1 1.0
Health provider first visited*
Public sector clinic 57 55.3
GP 34 33.0
Traditional healer 10 9.7
Secondary or tertiary hospital 2 1.9
Provider that referred patient for admission*
Public sector clinic 70 68.0
GP 24 23.3
Secondary or tertiary hospital 4 3.9
Self-referred 5 4.9
Common patterns of consultation
Visited public sector clinic only 34 32.7
Visited public sector clinic and GP 34 32.7
Visited GP only 9 8.7
Visited public sector clinic, GP and traditional healer 8 7.7
GP = Private general practitioner
*Data were missing in one patient for each of these variablesBMC Infectious Diseases 2008, 8:72 http://www.biomedcentral.com/1471-2334/8/72
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and making the first health care visit to a provider other
than a GP (p = 0.05).
In bivariate analysis provider delay was associated with
employment status. Those who were employed, had cas-
ual work or were studying had a shorter delay than those
not in employment (19 vs 39 days, p = 0.02). Multivariate
analysis was not performed given that only one factor was
associated with provider delay in bivariate analysis. Type
of TB and HIV status were not associated with patient or
provider delay.
Outcome
Sixty-eight percent (n = 71) were discharged home from
GF Jooste (three of whom were known to have died 8, 13
and 14 days after discharge), 11% (n = 11) died in hospi-
tal, 20% (n = 21) were referred to a TB hospital and 1 was
referred to another hospital. For those who were admit-
ted, the median duration of admission at GF Jooste was 9
days (IQR = 5.5–12).
Patient delay ≥ 14 days compared with delay < 14 days
was associated with a significantly increased likelihood of
transfer to a TB hospital (17 vs 4%, p = 0.04). Provider
delay of ≥ 30 days as compared to < 30 days was signifi-
cantly associated with mortality (12% vs 2%, p < 0.001).
Knowledge attitudes and beliefs
Ninety-five percent (n = 99) had heard about TB before
their illness. When asked what they knew about TB in an
open-ended question, 54% (n = 56) spoke about the treat-
ment, 38% (n = 39) spoke of the cough and/or constitu-
tional symptoms associated with TB and 25% (n = 26)
could give no details. 97% (n = 101) had heard about
HIV/AIDS before their illness. When asked what they
knew about HIV/AIDS, 63% (n = 65) mentioned sexual
transmission, 38% (n = 40) mentioned it was a deadly dis-
ease or that there is no cure, 13% (n = 14) mentioned the
importance of seeking medical attention or joining a sup-
port group, 12% (n = 12) mentioned blood transmission,
but 28% (n = 29) could give no details. In response to this
open-ended question, no patients mentioned that they
were aware of a heightened risk of TB in HIV-infected peo-
ple.
When asked in an open-ended question what they
thought was wrong with them when they got sick, 36% (n
= 37) said they did not know, 21% (n = 22) said they
thought it was HIV (all 22 of these patients were known
HIV positive before the admission), 20% (n = 21) thought
it was TB, 20% (n = 21) thought they had a cold or flu, 5%
(n = 5) attributed it to other medical problems, 3% (n =
3) to bewitchment and 2% (n = 2) to psychological dis-
tress.
When patients were asked what made them wait before
seeking medical attention, 41% (n = 43) replied that they
thought they would get better on their own, 31% (n = 32)
replied that they had not waited, 18% (n = 19) that they
had competing priorities and 13% (n = 13) cited physical
or emotional reasons. Competing priorities cited were a
lack of money, having to write exams, having to come to
Table 3: Characteristics significantly associated with patient and provider delay in bivariate analysis among the 104 patients with a 
diagnosis of tuberculosis*
Patient Delay
Characteristic, n (%) Median Patient Delay (IQR) p-value**
Gender
Male, 39 (37.5) 30 (7–60) 0.002
Female, 65 (62.5) 14 (7–21)
First visit
Private general practitioner, 34 (33.0) 10.5 (7–14) 0.01
Clinic, 57 (55.3) 14 (7–30)
Traditional healer, 10 (9.7) 21 (7–60)
Hospital, 2 (1.9) 30 (30–30)
Any cough reported
Yes, 81 (77.9) 14 (7–30) 0.003
No, 23 (22.1) 7 (4–14)
Provider Delay
Characteristic, n (%) Median Provider Delay (IQR) p-value**
Employment status
Unemployed/grant/pension, 77 (74.0) 39 (15–60) 0.02
Employed/casual work/student, 27 (26.0) 19 (7–46)
*The following variables were assessed for their bivariate relationship with patient and provider delay: gender, age, marital status, dependents, 
employment status, educational level, working before illness, type of TB, HIV status, first symptom, symptoms during course of illness, cough as 
symptom and as first symptom, consulted a traditional healer, place of first visit, sputum in primary care, chest radiograph in primary care, and 
home remedy used. For those not presented in the table, the associations were found to be non-significant.
**p-values represent comparisons of medians across different categories within each variable.BMC Infectious Diseases 2008, 8:72 http://www.biomedcentral.com/1471-2334/8/72
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the city for help and having not disclosed HIV status to
partner. The physical reasons cited related to being too
weak to attend the health services and the emotional rea-
sons related to feeling scared or depressed. When asked
what had prompted them to seek medical attention, 56%
(n = 58) cited symptoms of weakness or dizziness, 50% (n
= 52) shortness of breath, 16% (n = 17) a cough, 13% (n
= 14) chest pain, 14% (n = 15) abdominal symptoms, and
5% (n = 5) haemoptysis.
Discussion
Among those diagnosed with TB provider delay (median
30 days) was double that of patient delay (14 days). This
finding suggests that important diagnostic delays are
encountered in the primary care services by patients seek-
ing attention for TB symptoms. Patients visited multiple
primary health care providers and this lack of continuity
in care (or "doctor shopping") likely contributed to the
failure to investigate appropriately and provider delay in
diagnosis. Other studies have compared patient and pro-
vider delay, with some finding diagnostic delay more
attributable to patient delay [10-13], but others finding it
more related to provider delay [14-18].
The causes for patient delay in our study do not appear to
be due to lack of knowledge of TB or HIV (95% or more
had heard of TB and HIV). However, the majority of
patients were not attributing their symptoms to TB or HIV
suggesting that their knowledge of these diseases was not
being personalised. In other studies, health knowledge
and perceptions, health seeking behaviour and visits to
traditional healers have been shown to play a role in
delaying diagnosis [10,19-22]. In our study 14% had vis-
ited a traditional healer.
Reduced diagnostic sensitivity of sputum smears [23,24]
and chest radiographs [25] in HIV-infected people have
been reported as reasons for delay in the diagnosis of TB.
These factors may have played a role here (in 83 % of
those who were told the result of their sputum smear it
was negative), but only 38% of patients reported having
had a sputum sample sent and 48% a radiograph per-
formed. This suggests that the investigation of patients
presenting with TB symptoms to primary care providers
could be improved.
Patient delay was found to be longer for males, those who
first visited a provider other than a GP and those who had
a cough. In contrast, several other studies have demon-
strated that longer delay is associated with female gender
[13,14,22,26,27], attributed to gender differences in
health-seeking behaviour and health provider attitudes
and behaviour. Our findings that visiting a GP first was
associated with a shorter patient delay suggests that the
GP may be more accessible than other providers and that
those that can afford GP private fees will visit the GP ear-
lier. The finding that those with cough delay longer could
result from people seeking help when their cough has
been present for two weeks or longer as suggested by TB
public health messages and that in contrast other symp-
toms such as chest pain and neurological symptoms led
them to access the health care system earlier. Cough as the
only symptom was also associated with longer delay in
another study [16].
Patients required a median of 9 days hospitalisation at GF
Jooste and 20% of patients were referred to a TB hospital.
Longer patient delay resulted in increased need for referral
for inpatient TB treatment. This demonstrates the finan-
cial burden carried by the health service as a result of
patient delays. More importantly provider delay resulted
in increased mortality underlining the importance of
interventions to address this. Few other studies have spe-
cifically analysed the consequences of diagnostic delay.
One study conducted in the Gambia showed that longer
total delay was associated with an increased risk of death
[28].
Participants in this study were so sick that they required
hospitalisation for investigation and treatment, the
majority (75%) being bedbound by the time of admis-
sion. The fact that patients were so ill on admission after
having been ill for a median of 60 days suggests rapid pro-
gression of TB. This is probably attributable to the fact that
the majority were HIV-infected and the progression of TB
is more rapid in HIV-infected people [4]. Hospitalisation
is likely to be a frequent consequence of diagnostic delay
in HIV-infected people.
There are several limitations of our study. Firstly, we relied
upon patient recall of the history of their illness and
health seeking pattern, rather than documented records.
Because of the fear of criticism that may accompany
reporting of a visit to a traditional healer many patients
may not have disclosed this. The study was based on
patient interviews and thus could not adequately explore
health system issues such as referral pathways and investi-
gation practices. A further limitation was that this study
was conducted at a secondary hospital and thus only
patients who were sick enough to require referral for
admission were included. Thereby we focused on those
patients who had presented to the health service with TB
symptoms, but had not been initiated on TB treatment as
outpatients. This subgroup of patients is likely to be at
highest risk for a poor outcome as a consequence of delay.
Those patients who were timeously investigated and diag-
nosed with TB at a primary care level are not represented
in this study. This does mean that these results are not nec-
essarily generalisable to all patients presenting to the
health services with TB symptoms.BMC Infectious Diseases 2008, 8:72 http://www.biomedcentral.com/1471-2334/8/72
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Conclusion
Provider delay was double that of patient delay. Inde-
pendent risk factors for longer patient delay were male
gender, cough and first health care visit being to public
sector clinic (compared with a private GP). Patient delay
of 14 days or more was associated with increased need for
transfer to a TB hospital. Provider delay of 30 days or
more was associated with higher mortality.
These findings suggest a need for interventions to expedite
the diagnosis of TB in this setting, particularly in HIV-
infected patients. Strategies that need to be considered
relate to the health system (for example, steps by the pub-
lic sector to actively involve private GPs in the TB diagnos-
tic process given that the majority of patients visited a GP
during their illness), patient health seeking behaviour (for
example, education to promote continuity in the provid-
ers they visit), alternative diagnostic modalities (for exam-
ple, the implementation of clinical algorithms for
diagnosing smear negative TB) and the need to ensure
patients are properly investigated for chronic cough at the
primary level and referred to TB clinics.
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